Cargando…

The Immune Response: Targets for the Treatment of Severe Sepsis

The clinical process of severe sepsis is characterized by extreme inflammation interlinked with potent stimulation of the coagulation cascade often followed by a state of relative immune paralysis. In this paper, we will review many of the potential therapies directed at various steps along the infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernard, Aline M., Bernard, Gordon R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518958/
https://www.ncbi.nlm.nih.gov/pubmed/23251827
http://dx.doi.org/10.1155/2012/697592
_version_ 1782252598961635328
author Bernard, Aline M.
Bernard, Gordon R.
author_facet Bernard, Aline M.
Bernard, Gordon R.
author_sort Bernard, Aline M.
collection PubMed
description The clinical process of severe sepsis is characterized by extreme inflammation interlinked with potent stimulation of the coagulation cascade often followed by a state of relative immune paralysis. In this paper, we will review many of the potential therapies directed at various steps along the inflammatory cascade from modulation of inflammatory mediators eliciting the immune response, alteration of the host's immune response in both a stimulatory and depressive manner, and taming the overexuberant coagulation response triggered by the fierce coagulation-inflammation cycle. Finally, we will discuss further opportunities for research to improve our ability to design effective therapies.
format Online
Article
Text
id pubmed-3518958
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-35189582012-12-18 The Immune Response: Targets for the Treatment of Severe Sepsis Bernard, Aline M. Bernard, Gordon R. Int J Inflam Review Article The clinical process of severe sepsis is characterized by extreme inflammation interlinked with potent stimulation of the coagulation cascade often followed by a state of relative immune paralysis. In this paper, we will review many of the potential therapies directed at various steps along the inflammatory cascade from modulation of inflammatory mediators eliciting the immune response, alteration of the host's immune response in both a stimulatory and depressive manner, and taming the overexuberant coagulation response triggered by the fierce coagulation-inflammation cycle. Finally, we will discuss further opportunities for research to improve our ability to design effective therapies. Hindawi Publishing Corporation 2012 2012-12-03 /pmc/articles/PMC3518958/ /pubmed/23251827 http://dx.doi.org/10.1155/2012/697592 Text en Copyright © 2012 A. M. Bernard and G. R. Bernard. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Bernard, Aline M.
Bernard, Gordon R.
The Immune Response: Targets for the Treatment of Severe Sepsis
title The Immune Response: Targets for the Treatment of Severe Sepsis
title_full The Immune Response: Targets for the Treatment of Severe Sepsis
title_fullStr The Immune Response: Targets for the Treatment of Severe Sepsis
title_full_unstemmed The Immune Response: Targets for the Treatment of Severe Sepsis
title_short The Immune Response: Targets for the Treatment of Severe Sepsis
title_sort immune response: targets for the treatment of severe sepsis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518958/
https://www.ncbi.nlm.nih.gov/pubmed/23251827
http://dx.doi.org/10.1155/2012/697592
work_keys_str_mv AT bernardalinem theimmuneresponsetargetsforthetreatmentofseveresepsis
AT bernardgordonr theimmuneresponsetargetsforthetreatmentofseveresepsis
AT bernardalinem immuneresponsetargetsforthetreatmentofseveresepsis
AT bernardgordonr immuneresponsetargetsforthetreatmentofseveresepsis